News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Evolutec Ltd Gets Positive Pre-clinical Data On Lead Molecule
February 28, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Evolutec Group PLC said it got a positive metabolic result from laboratory work on its lead molecule, rEV131, which the company is trying to develop into treatments for illnesses such as hayfever and asthma.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
Europe
MORE ON THIS TOPIC
Huntington’s disease
Exit of Roche’s embattled Huntington’s drug ‘tightens’ case for Wave’s more selective ASO
July 13, 2026
·
4 min read
·
Heather McKenzie
Insights
From sequence to scale: Gene editing’s new era in biologics manufacturing
July 10, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Antibody-drug conjugates
GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
July 10, 2026
·
1 min read
·
Gabrielle Masson
Cardiovascular disease
AstraZeneca, Ionis’ Wainua woes send waves across ATTR-CM space
July 10, 2026
·
3 min read
·
Tristan Manalac
